Novinky v imunoterapii refrakterní a relabující akutní lymfoblastické leukemie dospělých
| Title in English | News in the immunotherapy of relapsed and refractory adult acute lymphoblastic leukemia |
|---|---|
| Authors | |
| Year of publication | 2017 |
| Type | Popularization text |
| MU Faculty or unit | |
| Citation | |
| Description | Acute lymphoblastic leukemia (ALL) is the most common oncological disease in childhood. It is a rare malignancy in the adults. While there are very good treatment achievements in children, the prognosis of adult patients remains unsatisfactory mainly due to a high incidence of treatment-resistant relapses. There is a great progress in both diagnostics and treatment of this disease in past few years, especially thanks to introducing of new drugs into a daily clinical practise. This summary is focused on news in the treatment of relapsed and refractory adult ALL with highlights on immunotherapy. |